Drug Profile
Research programme: skin disorders therapeutics - SWITCH Biotech
Alternative Names: Skin disorders therapeutics - Switch Biotech; SWT 01113; SWT 05141Latest Information Update: 04 Sep 2023
Price :
$50
*
At a glance
- Originator SWITCH Biotech
- Class Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Acne vulgaris; Actinic keratosis; Alopecia; Atopic dermatitis; Onychomycosis; Psoriasis; Skin ulcer; Vitiligo
Most Recent Events
- 04 Sep 2023 Discontinued - Preclinical for Alopecia in Germany (Topical) (SWITCH Biotech website, September 2023)
- 04 Sep 2023 Discontinued - Preclinical for Atopic dermatitis in Germany (Topical) (SWITCH Biotech website, September 2023)
- 04 Sep 2023 Discontinued - Preclinical for Psoriasis in Germany (Topical) (SWITCH Biotech website, September 2023)